The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Blood Transfusion Diagnostics Market Research Report 2024

Global Blood Transfusion Diagnostics Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1887717

No of Pages : 86

Ask Your Query

Synopsis

Intravenous transfer of blood or blood products is known as blood transfusion. Replacement of lost blood components can be done with the help of blood transfusion. Blood components like red blood cells, white blood cells, platelets, clotting factors and plasma are mostly transfused. These blood components are of great importance to laboratories and hospitals during an emergency or a critical case of large volume of blood loss. RBC transfusion is done when hemoglobin levels fall below 100g/L. Blood collected from the donor has to be screened for a number of infectious disease before transfusion. Thus, blood transfusion diagnostics play an important role in blood transfusion in order to avoid infection to both the receiver and healthcare staff.

The global Blood Transfusion Diagnostics market was valued at US$ 3034.7 million in 2023 and is anticipated to reach US$ 4338.7 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Blood Transfusion Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Transfusion Diagnostics.

Report Scope

The Blood Transfusion Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Transfusion Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Blood Transfusion Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Grifols
  • Thermo Fisher Scientific
  • Roche
  • bioMérieux
  • Bio-Rad
  • Ortho Clinical Diagnostics
  • Becton Dickinson
  • Fujirebio
  • DiaSorin(American Standard Companies)
  • Beckman Coulter
  • Diagast
  • Abbott
  • BAG Health Care
  • Quidel

Segment by Type

  • ELISA
  • NAT
  • Western Blot Assays
  • Fluorescence Assay
  • Other Technology

Segment by Application

  • Hospitals
  • Clinics
  • Blood Banks
  • Laboratories
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Transfusion Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Transfusion Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ELISA
1.2.3 NAT
1.2.4 Western Blot Assays
1.2.5 Fluorescence Assay
1.2.6 Other Technology
1.3 Market by Application
1.3.1 Global Blood Transfusion Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Blood Banks
1.3.5 Laboratories
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Transfusion Diagnostics Market Perspective (2019-2030)
2.2 Blood Transfusion Diagnostics Growth Trends by Region
2.2.1 Global Blood Transfusion Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Transfusion Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Blood Transfusion Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Blood Transfusion Diagnostics Market Dynamics
2.3.1 Blood Transfusion Diagnostics Industry Trends
2.3.2 Blood Transfusion Diagnostics Market Drivers
2.3.3 Blood Transfusion Diagnostics Market Challenges
2.3.4 Blood Transfusion Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Transfusion Diagnostics Players by Revenue
3.1.1 Global Top Blood Transfusion Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Blood Transfusion Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Blood Transfusion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Transfusion Diagnostics Revenue
3.4 Global Blood Transfusion Diagnostics Market Concentration Ratio
3.4.1 Global Blood Transfusion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Transfusion Diagnostics Revenue in 2023
3.5 Blood Transfusion Diagnostics Key Players Head office and Area Served
3.6 Key Players Blood Transfusion Diagnostics Product Solution and Service
3.7 Date of Enter into Blood Transfusion Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Transfusion Diagnostics Breakdown Data by Type
4.1 Global Blood Transfusion Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Blood Transfusion Diagnostics Forecasted Market Size by Type (2025-2030)
5 Blood Transfusion Diagnostics Breakdown Data by Application
5.1 Global Blood Transfusion Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Blood Transfusion Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Transfusion Diagnostics Market Size (2019-2030)
6.2 North America Blood Transfusion Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Transfusion Diagnostics Market Size by Country (2019-2024)
6.4 North America Blood Transfusion Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Transfusion Diagnostics Market Size (2019-2030)
7.2 Europe Blood Transfusion Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Transfusion Diagnostics Market Size by Country (2019-2024)
7.4 Europe Blood Transfusion Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Transfusion Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Blood Transfusion Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Transfusion Diagnostics Market Size (2019-2030)
9.2 Latin America Blood Transfusion Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Transfusion Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Blood Transfusion Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Transfusion Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Blood Transfusion Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Detail
11.1.2 Grifols Business Overview
11.1.3 Grifols Blood Transfusion Diagnostics Introduction
11.1.4 Grifols Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.1.5 Grifols Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Blood Transfusion Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Blood Transfusion Diagnostics Introduction
11.3.4 Roche Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.3.5 Roche Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Detail
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Blood Transfusion Diagnostics Introduction
11.4.4 bioMérieux Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.4.5 bioMérieux Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Detail
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Blood Transfusion Diagnostics Introduction
11.5.4 Bio-Rad Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.5.5 Bio-Rad Recent Development
11.6 Ortho Clinical Diagnostics
11.6.1 Ortho Clinical Diagnostics Company Detail
11.6.2 Ortho Clinical Diagnostics Business Overview
11.6.3 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Introduction
11.6.4 Ortho Clinical Diagnostics Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.6.5 Ortho Clinical Diagnostics Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Detail
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Blood Transfusion Diagnostics Introduction
11.7.4 Becton Dickinson Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.7.5 Becton Dickinson Recent Development
11.8 Fujirebio
11.8.1 Fujirebio Company Detail
11.8.2 Fujirebio Business Overview
11.8.3 Fujirebio Blood Transfusion Diagnostics Introduction
11.8.4 Fujirebio Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.8.5 Fujirebio Recent Development
11.9 DiaSorin(American Standard Companies)
11.9.1 DiaSorin(American Standard Companies) Company Detail
11.9.2 DiaSorin(American Standard Companies) Business Overview
11.9.3 DiaSorin(American Standard Companies) Blood Transfusion Diagnostics Introduction
11.9.4 DiaSorin(American Standard Companies) Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.9.5 DiaSorin(American Standard Companies) Recent Development
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Detail
11.10.2 Beckman Coulter Business Overview
11.10.3 Beckman Coulter Blood Transfusion Diagnostics Introduction
11.10.4 Beckman Coulter Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.10.5 Beckman Coulter Recent Development
11.11 Diagast
11.11.1 Diagast Company Detail
11.11.2 Diagast Business Overview
11.11.3 Diagast Blood Transfusion Diagnostics Introduction
11.11.4 Diagast Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.11.5 Diagast Recent Development
11.12 Abbott
11.12.1 Abbott Company Detail
11.12.2 Abbott Business Overview
11.12.3 Abbott Blood Transfusion Diagnostics Introduction
11.12.4 Abbott Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.12.5 Abbott Recent Development
11.13 BAG Health Care
11.13.1 BAG Health Care Company Detail
11.13.2 BAG Health Care Business Overview
11.13.3 BAG Health Care Blood Transfusion Diagnostics Introduction
11.13.4 BAG Health Care Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.13.5 BAG Health Care Recent Development
11.14 Quidel
11.14.1 Quidel Company Detail
11.14.2 Quidel Business Overview
11.14.3 Quidel Blood Transfusion Diagnostics Introduction
11.14.4 Quidel Revenue in Blood Transfusion Diagnostics Business (2019-2024)
11.14.5 Quidel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock